Description
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Product Unit Size | Cost | Quantity | Stock |
---|
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Cas No. | 1022958-60-6 |
---|---|
Purity | ≥98% |
Formula | C28H35ClN6O3 |
Formula Wt. | 539.08 |
IUPAC Name | (1S,2S,3R,4R)-3-[(5-Chloro-2-{[(7S)-1-methoxy-7-(4-morpholinyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino}-4-pyrimidinyl)amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide |
Synonym | CEP 28122, CEP28122 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Cheng M., Quail M., et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 11(3):670-79 (2012). PMID: 22203728.
AhR antagonist.
μOR and δOR agonist, D2/D3 DA potentiator.
Inhibits HCV replication
Curcumin derivative; AMPK activator, STAT3 and ...
Tropane alkaloid found in plants in the Solanac...
ITC, sulforaphane analog.
Plasminogen inhibitor.
ATP-sensitive K+ channel blocker, potential RyR...
Histamine H1 antagonist.
Peptide, derivative of AT II, involved in vasoc...
CDK9 inhibitor.
SK K+ channel blocker, EGFR inhibitor.
BTK inhibitor.
PDGFR and c-Kit inhibitor.
NSAID; COX-1/2 inhibitor.
Indoloquinazoline alkaloid found in Evodia; COX...
FIASMA, μOR agonist, potential HCN channel blo...
Endogenous peptide hormone, increases extracell...
HIV protease inhibitor.
Alcoholic β-glucoside found in willow bark, sa...